Table 2 : Outcome measures after 15 weeks of intervention.

Measure Group (A) (n=20) X±SD Group (B) (n=20) X±SD Mean difference p-value
pre post pre post
Body weight(Kg) 105±2.15 94.75±1.9 100±2.9 94.15± 3.1 -0.6±3.7 0.8
BMI(Kg/m2) 39.01±0.67 35.45±0.59 39.14±0.87 36.59±0.98 -1.13±1.1 0.33
WC(cm) 114.3±1.68 102.8±1.5 116.4±1.85 109.4±2.15 -6.5±2.6 0.017
LANSS 21.75±0.45 16.85±0.69 21.80±0.42 20.45±0.37 -3.6±0.7 0.0001
LEFS 55.30±1.18 66.50±1.12 56.35±1.24 65.30±1.70 1.2±2.03 0.55

 OGTT:            

FBG(mg/dl) 118.1±1.11 89.65±2.14 116.8±1.37 96.2±2.01 -6.5±2.9 0.03
60-minute PP(mg/dl) 182.2±8.40 120.5±4.6 206.2±5.55 163.3±4.17 -42.75±6.2 0.0001
90-minute PP(mg/dl) 175.4±8.2 115.6±3.6 188±3.75 148.5±2.5 -32.85±4.5 0.0001
120-minute PP(mg/dl) 156.6±5.47 100±1.5 166.45±2.2 120.2±1.5 -20.15±2.2 0.0001

X: mean; SD: standard deviation; MD: mean difference; BMI: body mass index;
WC: waist circumference;
LANSS: Leeds Assessment of Neuropathic symptoms and signs Scale;
LEFS: lower extremity functional scale; OGTT: oral glucose tolerance test;
FBG: fasting blood glucose; PP: post prandial

Hamed et al.Physical Therapy and Rehabilitation  2014 1:4DOI : 10.7243/2055-2386-1-4